These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063 [TBL] [Abstract][Full Text] [Related]
5. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1. Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097 [TBL] [Abstract][Full Text] [Related]
6. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806 [TBL] [Abstract][Full Text] [Related]
7. Vaccines against influenza A (H5N1): evidence of progress. Poland GA; Sambhara S J Infect Dis; 2008 Sep; 198(5):629-31. PubMed ID: 18694337 [No Abstract] [Full Text] [Related]
8. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216 [TBL] [Abstract][Full Text] [Related]
9. A universal epitope-based influenza vaccine and its efficacy against H5N1. Adar Y; Singer Y; Levi R; Tzehoval E; Perk S; Banet-Noach C; Nagar S; Arnon R; Ben-Yedidia T Vaccine; 2009 Mar; 27(15):2099-107. PubMed ID: 19356612 [TBL] [Abstract][Full Text] [Related]
10. [Influenza type A (H5N1) virus infection]. Engin A Mikrobiyol Bul; 2007 Jul; 41(3):485-94. PubMed ID: 17933264 [TBL] [Abstract][Full Text] [Related]
11. [Registration of the first human vaccine against the highly pathogenic avian influenza A(H5N1) virus: considerations]. de Jong JC; Osterhaus AD Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2113-5. PubMed ID: 18856026 [TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663 [TBL] [Abstract][Full Text] [Related]
13. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Holman DH; Wang D; Raja NU; Luo M; Moore KM; Woraratanadharm J; Mytle N; Dong JY Vaccine; 2008 May; 26(21):2627-39. PubMed ID: 18395306 [TBL] [Abstract][Full Text] [Related]
14. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
15. Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic. Qin CF; Qin ED Chin Med J (Engl); 2008 Aug; 121(15):1481-3. PubMed ID: 18959131 [No Abstract] [Full Text] [Related]
16. A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. Ehrlich HJ; Müller M; Fritsch S; Zeitlinger M; Berezuk G; Löw-Baselli A; van der Velden MV; Pöllabauer EM; Maritsch F; Pavlova BG; Tambyah PA; Oh HM; Montomoli E; Kistner O; Noel Barrett P J Infect Dis; 2009 Oct; 200(7):1113-8. PubMed ID: 19712040 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies come of age. Ledford H Nature; 2008 Sep; 455(7212):437. PubMed ID: 18818613 [No Abstract] [Full Text] [Related]
18. One step closer to universal influenza epitopes. Li OT; Poon LL Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695 [TBL] [Abstract][Full Text] [Related]
19. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library. Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ Virol J; 2008 Oct; 5():130. PubMed ID: 18957074 [TBL] [Abstract][Full Text] [Related]
20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]